01 January 2001
Omeprazole therapy and salivary flow rate in duodenal ulcer patients.
Zbigniew Namiot, Jan Stasiewicz, Maciej Kralisz, Małgorzata Kozuszyńska-Topór, Adam R Markowski, Fouad K Aljanaby, Andrzej Kemona, Jan GórskiMed Sci Monit 2001; 7(2): CR276-281 :: ID: 421149
Abstract
BACKGROUND: Previous reports have shown that in some reflux-oesophagitispatients omeprazole therapy alters salivary secretion. The aim of the study was to examine this effectin duodenal ulcer patients.
MATERIAL AND METHODS: Thirty nine Helicobacter pylori positive subjects ofboth sexes, predominantly men, were recruited for the study. They were taking for two weeks only omeprazole(n = 17), or omeprazole in combination with either amoxycillin or amoxycillin and tinidazole (n = 22).Salivary secretion was assessed before and at the end of the treatment, both in basal conditions andduring a gastric secretory test. Gastric secretion was monitored concurrently with salivary flow rate.Additionally gastritis score and serum gastrin levels were assessed.
RESULTS: Basal salivary secretionsremained unchanged in patients on omeprazole monotherapy, but decreased in five of eight saliva collectionperiods in patients on eradication regimens. During the gastric secretory test, salivary secretions fellin both groups, but only after pentagastrin stimulation (in one collection period in patients on omeprazole,and in three collection periods in patients on eradication therapy). The observed changes in salivarysecretion were inversely related to the pre-treatment gastric pH values.
CONCLUSION: The influence ofomeprazole and omeprazole-based eradication therapies on salivary flow rate is presumably secondary tochanges in gastric pH values and is likely to be related to oesophago-salivary reflex generation.
Keywords: Duodenal Ulcer, Duodenal Ulcer, omeprazole, Salivation
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952